Find an expert

Andrew Martin is inaugural Professor of Innovative Clinical Trials and leads the University of Queensland’s cLinical Trials cApability (ULTRA) program. Andrew was Professor in the biostatistics group at the NHMRC Clinical Trials Centre University of Sydney. He maintains that role in an honorary capacity since joining UQ. Prior to academia, Andrew held senior biostatistics roles within research-based pharmaceutical organisations (Pfizer and Roche).

orcid ID: 0000-0001-5804-2295

Scopus Author ID: 57223730436

Grants

Category 1: $14.3M Category 3: $131.8M

Grants: 2023 Clinical Trials and Cohort Studies Grant ID 2032441 ($1,362,000): P3BEP Trial - Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours; 2022 NHMRC Partnership Projects Grant 2015773 ($1,166,592): Strengthening healthcare systems with Patient Reported Outcome Measures (PROMs); 2020 CA ($600,000): Immuno-metabolic biomarkers for metastatic prostate cancer treatment response; 2018 MRFF Grant APP1170066 ($1,596,631): WHEAT Study on reducing NEC in preterm infants; 2018 CA Grant APP1158397 ($479,375): SCORE trial for shared colorectal cancer care; 2018 CA Grant APP1159837 ($600,000): P3BEP Trial for advanced germ cell tumours; 2018 NHMRC Project Grant APP1159787 ($1,587,163): BCG+MM Trial for bladder cancer; 2016 Victorian Cancer ($300,000): SCORE project on shared care of Colorectal cancer survivors; 2015 CA Priority-driven Collaborative Cancer Research Scheme ($443,307): LEAD - Lung cancer diagnostic and treatment pathways; 2015 NHMRC Project Grant 1108328 ($624,824): Oral Nicotinamide for skin cancer chemoprevention after Transplant; 2014 Co-funded Grant 1079794 ($597,095): Methoxyflurane to reduce discomfort of prostate biopsy; 2013 NHMRC Project Grant 1064121 ($880,425): CHEST Australia project for quicker primary care consultations in lung cancer; 2012 NHMRC Project Grant APP1047100 ($2,203,171): Bovine lactoferrin study on low birthweight infants; 2011 National Breast Cancer Foundation ($199,606): Physical well-being for metastatic breast cancer; 2011 NHMRC Project Grant 1028555 ($187,018): Evidence on reduced child obesity rates; 2011 NHMRC Project Grant 1026977 ($586,691): Oral nicotinamide for skin cancer prevention; 2011 Australasian College of Dermatologists grant ($25,000): Nicotinamide for non-melanoma skin cancer in renal transplant recipients; 2010 NHMRC Project Grant 1007628 ($369,208): NEU-HORIZONS study on riluzole for oxaliplatin neurotoxicity; 2010 NHMRC Project Grant 1003414 ($564,410): Phase II prostate cancer follow-up trial in primary care.

Statistical lead on the following projects receiving industry funding with USyd as administering institution: ENZARAD NCT02446444 ($12,178,000); ENZAMET NCT02446405 ($20,408,129); INTEGRATE ACTRN12612000239864 ($6,900,000); INTEGRATE IIa ACTRN12616000420448 ($22,264,248); INTEGRATE IIb NCT04879368 ($36,330,215); DASL-HiCaP NCT04136353 ($33,777,579).

Richard is a cultural anthropologist in the School of Social Science at UQ. His research focuses on Indigenous land rights and native title, cultural heritage, Australian anthropology, and Australian history and culture.

Richard has a PhD in social and cultural studies from The University of Western Australia. His PhD research examined relations between Indigenous and non-Indigenous people in the remote Gulf Country of northern Australia, where he began fieldwork in 2007. After completing his PhD in 2012, Richard has continued to work in the Gulf Country on a range of academic and applied research projects, continuing to develop friendships and collaborations with Indigenous and non-Indigenous people across this area.

Since joining UQ in 2012, Richard has published a range of scholarly articles in leading academic journals as well as the book, The Gulf Country: The story of people and place in outback Queensland (Allen & Unwin, 2019). He has also carried out extensive applied research with Indigenous people on native title claims and cultural heritage matters across Australia, and given expert evidence in the Federal Court of Australia.

Professor Darren Martin FTSE

A Translational Materials Scientist and Intensive Connector, Darren's work sits at the nexus of three key themes of strong fundamental materials science, safe biomaterials and nanomaterials and scalable advanced manufacturing

Darren has always had a strong passion for translation, as evidenced by the following four major research translation outputs, which share the capacity of advanced materials to enable impacts in health, sustainability, and social empowerment:

1996-2012 - Aortech Biomaterials Ltd: We developed a more biostable pacemaker lead insulation which is now implanted in over 80 million people worldwide (Abbott Medical).

2001-2020 - TenasiTech Pty Ltd: In 2020 our scratch resistant and break-proof acrylic glass technology was sold to RTP, a multinational plastics compounder who now sell into several large markets (appliances, personal care, construction, cell phone cases, automotive parts, etc).

2011-2022 - Spinifex Nanocellulose Platform Technology: In 2021, this technology was licensed to Brisbane startup Trioda Medical Pty Ltd for the development of injectable medical gels.

2015-Present - Sorghum-derived Microfibrillated Cellulose (MFC): My team have demonstrated that sorghum grasses can be pulped and refined into MFC in a far more sustainable manner than wood biomass.

International Collaborators and Industry Partners

Professor Martin’s current international collaborators include Stony Brook University (USA), DTU (Denmark) and IIT-Delhi (India). He also has several materials co-development projects and collaborations with companies such as Advanta Seeds, GSA Innovation, Opal Paper, Cardia Bioplastics, GMG, GrapheneX, Duromer, OPS, Dulux, Australian Wood Fibre and others.

Prizes, Honours and Awards

Excellence & Commercialisation

• 2020 - UTS Chancellor’s Award (awarded to the top Alumni from the whole of UTS each year)

• 2020 - UTS Alumni Award for Excellence - Faculty of Science • 2016 & 2019 - 2 UQ Partners in Research Excellence Awards (PIREAs) (Spinifex project Bulugudu partnership)

• 2015 - State finalist in the 2015 Telstra Business Awards (TenasiTech Pty Ltd)

• 2010 - UQ Faculty of Engineering, Architecture and Information Technology Commercialisation Award

• 2010 - Engineers Australia Nanoengineering Panel

• 2007 - iLab Prize at the QLD Enterprise Awards (lead to TenasiTech pre-seed investment from UniSeed)

Service & Leadership

• 2021 - ATSE Reconciliation Action Plan reference group and Industry and Innovation Forum

• 2021 - ATSE President Nominations and Interview Committee to deliberate on the current ATSE President

• 2019 - UQ Teams Leadership Award (Spinifex project Bulugudu partnership)

• 2019 - Business Higher Education Round Table Award (Community Engagement Bulugudu partnership)

• 1993 - Member of the Royal Australian Chemical Institute RACI and the RACI QLD Polymer Group

Dr Veronica is an Advance Queensland Industry Research Fellow, under the supervision of Professor Esteban Marcellin and Professor Lars Nielsen. She received her Biotechnology Engineering degree at the University of Chile in 2007 and completed her Ph.D. in Systems Biology at The University of Queensland in 2014. After completing her Ph.D. she performed 2 years of postdoctoral training at The University of Queensland, as part of a collaboration project with Universidad de Chile. Both Ph.D. studies and postdoctoral training were financially supported by the Chilean Government, under a competitive scholarship and fellowship, respectively. Later she worked as a Postdoctoral Research Fellow- Biopharmaceutical Upstream Bioprocessing at the ARC Training Centre for Biopharmaceutical Innovation (CBI), The University of Queensland.

She has some teaching experience. She had performed tutorial teaching in several courses at Universidad de Chile and the University of Queensland. In 2016 she was in charge of the Beer and Biofuels practical, part of the subject: Biomolecular Engineering (CHEE4020) of the chemical engineering department at The University of Queensland. In 2023 she gave an invited speaker lecture about cell culture optimization at the Biologics course (BIOT7018) at The University of Queensland.

Her research focuses on the improvement of biopharmaceutical production using mammalian cells. She is specifically interested in (1) the development of computational tools for metabolic systems biology, and (2) the improvement of upstream bioprocess. On the tools side, she has worked on the integration of thermodynamic principles and omics datasets into genome-scale models to estimate metabolic flux distributions; and developed a method for the estimation of dynamic metabolic fluxes. She has used these tools to describe experimental mammalian cells data and to guide the improvement of biopharmaceutical production processes. She has also been involved in the development of the latest human and CHO genome-scale models. On the process side, she worked on the improvement of a high cell density culture, using systems biology tools to develop a cell line adapted to high cell density and to develop an improved upstream bioprocess.

Her current project focuses on the development of a platform to generate good producer cell factories of difficult-to-express proteins.

Dr Mason began at The University of Queensland in late 2014 after holding academic positions at The University of Sydney and QUT. Prior to joining UQ he also worked as a catastrophe risk researcher for the industry-focused research centre, Risk Frontiers at Macquarie University. Matthew’s key areas of interest and expertise lie in the fields of:

• Wind Engineering
• Stochastic modelling of hazards, including convective storms and tropical cyclones
• Probabilistic modelling of structural and infrastructure vulnerability to wind, water and hail
• Catastrophe loss modelling for natural hazards
• Modelling and observation of the atmospheric boundary layer
• Wind tunnel testing and analysis
• Disaster insurance

Dr Mason is currently the Chair of the Standards Australia wind loading sub-committee responsible for maintenance of AS/NZS1170.2.

Karen is a Senior Research Fellow at QAAFI, University of Queensland, where she leads a research group dedicated to advancing crop improvement through cutting-edge genomic and biotechnological approaches. Her team applies targeted and precise genetic manipulation to unravel complex biological systems and translate these discoveries into innovative breeding programs. Currently, her research focuses on modulating crop developmental patterning to enhance abiotic stress tolerance, with the long-term goal of developing high-performing crops tailored for specific environments. The group is actively expanding its research portfolio to include crops such as sorghum, barley, tropical pasture grasses, and both tropical and temperate legumes. Karen is a passionate advocate for biotechnology, championing both GM and gene-edited plants to promote sustainable crop and food production.

Barbara’s research uses social psychological theory to solve real social problems. Over 19 years she has collaborated with a range of industry partners (e.g., Australian Red Cross Lifeblood; state police agencies) to design and evaluate theory-based solutions to problems as diverse as how to minimise bias in investigating allegations of sexual assault to how to maximise blood donor appointment attendance. She has over 100 peer reviewed publications including many focused on gender, prejudice, discrimination, and SoHO donor recruitment and retention that have been published in Annals of Behavioral Medicine, Psychology of Women Quarterly, Journal of Personality and Social Psychology, Law & Human Behavior, Transfusion, Transfusion Medicine Reviews and and other journals.

Dr Eve Massingham was a Senior Research Fellow with the School of Law at The University of Queensland, looking at the diverse ways in which the law constrains or enables autonomous functions of military platforms, systems and weapons, from September 2019 - August 2022. She is the co-editor of Ensuring Respect for International Humanitarian Law (Routledge, 2020) and she has published widely in the field of international humanitarian law. Eve has spent most of her career with the International Red Cross and Red Crescent Movement. Eve is currently working in the International Humanitarian Law team with the Australian Red Cross, returning in late 2025 after having worked in this team for many years prior to 2016. Eve has worked with the International Committee of the Red Cross as the Regional Legal Adviser for the Regional Delegation in the Pacific (2025), as the Regional Legal Adviser for East Africa (2016-2018), Regional Legal Adviser for Southern Africa (ad interim 2019) and as a Policy Adviser in the Arms and Conduct of Hostilities Unit in Geneva (2022-2023). She began her career at (then) Freehills (admitted 2004) and was an Associate to Justice Collier at the Federal Court of Australia. Eve has also served as an Australian Army Reserve Officer, graduating from Duntroon in 2001 as a member of the Queensland University Regiment. Eve holds qualifications including a Bachelor of Law (Hons) from Queensland University of Technology, a Master of International and Community Development from Deakin University, an LLM (Distinction) from King's College London (where she attended as a Chevening Scholar) and a PhD from the University of Queensland.

Dr Michèle Masson-Trottier is a certified speech-language pathologist and postdoctoral research fellow at the University of Queensland. Her work bridges speech-language therapy, neuroimaging, and open science to improve communication outcomes in individuals with post-stroke aphasia and neurodegenerative conditions such as primary progressive aphasia and Alzheimer’s disease.

Her expertise includes:

• Evidence-based language therapy development and adaptation

• Therapy-induced neuroplasticity and functional neuroimaging (rs-fMRI, task-fMRI)

• Technology-supported communication interventions

• Culturally and linguistically responsive care models

• Reproducible, containerised neuroimaging workflows for clinical populations

As part of the Neurodesk project, she leads the development of open, accessible neuroimaging tools tailored to clinical research needs, including lesion segmentation and cortical atrophy pipelines. Her work reduces technical barriers for clinician-researchers and promotes inclusive, translational science.

Her research is widely disseminated through peer-reviewed publications, international collaborations, and clinical knowledge translation. She is committed to making neuroscience tools and evidence-based interventions more usable and impactful across healthcare contexts.

Keywords: aphasia, neuroimaging, speech-language pathology, primary progressive aphasia, open science, therapy effectiveness, neuroplasticity, dementia, communication disorders, translational neuroscience

Dr Mostafa Kamal Masud is a CCQ Next Generation Cancer Research Fellow at the Australian Institute for Bioengineering & Nanotechnology (AIBN), the University of Queensland (UQ). In 2020, he received his PhD in Medical Biotechnology Diagnostics and Nanobiotechnology from AIBN, UQ. He received his MS and B.Sc. (Hons.) in Chemistry from Shahjalal University of Science and Technology (SUST), Sylhet-3114, Bangladesh. After completing his PhD, he was awarded a prestigious JSPS Postdoctoral Fellowship (success rate >10%) from Japan and served as a Postdoctoral Fellow at Japan's National Institute for Materials Science (NIMS).He recently been awarded a highly prestigious ARC DECRA fellowship for the period 2024-2026 and a QLD Cancer Council fellowship for the period 2024–2028. His research focuses on the development of novel nanostructures and nanodiagnostic technologies to address critical issues in medical diagnosis. As an early career researcher, he has an excellent track record with more than 60 peer-reviewed publications in prestigious and high-impact journals in the area that achieve <2800 citations with an h-index of 29 (Scholar google link: https://bit.ly/2Vtv67l). He has developed new classes of superparamagnetic nanostructures and fabricated novel biosensors for the detection of disease-specific biomolecular targets e.g., for miRNA, DNA, exosome and protein biomarker detection that have proven to be easy and effective, allowing for rapid diagnosis with minimal equipment. He made a major contribution to nanotechnology integrated-analytical and diagnostic fields by providing analytical and technological input as well as developing key collaborations with clinicians and biologists for translational research. His strategy is to create nano-architecture point-of-care diagnostic technology for early diagnosis of cancer that could hopefully lead to a healthy and happier life for humans.

Dr Sabine Matook is an Information Systems Professor at the UQ Business School, University of Queensland. Dr Matook received her doctoral degree from the Technische Universität (TU) Dresden, Germany.

Research

Sabine's scientific work focuses on data and IT artifacts in the two areas of information systems development (ISD) and social media. In these fields, Professor Matook's work examines how humans and technology function and interact with each other and with the environments in which they operate. Her core focus is on data, and Professor Matook applies analytical techniques and scientific procedures to datasets, extracting insights for organizational operations. In her research, she designs, builds, and deploys analytic frameworks, reference models, and AI tools to generate information for strategic planning and decision-making.

Within the context of ISD, she seeks to understand why and how data, information needs, and the behaviors of teams and individuals dynamically impact the design and development of the IT artifact, including technology-mediated teams (e.g., human-AI hybrids). Her interests also motivate work on algorithmic technologies for social artificial intelligence in social media. Based on Professor Matook's data-driven findings, key organizational decision-makers gain insights into how to respond to sudden virtual events, prevent data threats, and protect personal information.

In 2022, Sabine was recognized for her excellence in science and her scientific publications with the 2022 UQ Business School Research Award. Already in 2009, Professor Matook received this scientific honour for her research and development work.

Sabine is a Senior Research Fellow with the Weizenbaum Institute for the Networked Society - The German Internet Institute. She has also held visiting positions at the University of Arizona (Eller College of Management), Georgia State University (J. Mack Robinson College of Business), the University of Louisville, Technische Universität Dresden (Germany), Vienna University of Economics and Business Administration (Austria), and the University of La Serena (Chile).

Her research is funded by the Australian Research Council (ARC) Discovery Project (single CI) Grants in the fields of Sabine's expertise, especially information systems development and social media.

Sabine's journal articles, published and presented at ICIS 2023, coauthored with Nadia Bello Rinaudo and Alan Dennis, about "AI Algorithms and Time Experience in Social Media: Explaining Discontinued Use," received the Best-Paper Runner-up award (selected from more than 200 accepted short papers).

Dr. Matook's work has appeared in MIS Quarterly, Journal of Management Information Systems, European Journal of Information Systems, Information Systems Journal, the Journal of Strategic Information Systems, the International Journal of Operations & Production Management, the Journal of Business Research, Decision Support Systems, and the Scandinavian Journal of Information Systems. Over the years, Sabine Matook has presented numerous research papers at international conferences, including the ICIS, ECIS, and PACIS.

Teaching and Learning

Sabine Matook is a passionate educator and a champion for work-integrated learning in higher education to train the next generation of scientists.

In February 2024, Sabine was recognised by the 2023 Australian Awards for University Teaching (AAUT) with a Citation for Outstanding Contributions to Student Learning for "For innovatively designing a digital work-integrated learning partnership approach that enhances students' employability in Business Information Systems while inspiring them to ‘give-back’ to community organisations."

She received the 2022 UQ Citation for Outstanding Contributions to Student Learning and the 2021 Teaching Excellence Award of the UQ Faculty BEL on "Enhancing Employability". She was also awarded the 2021 UQ Business School Award for "Innovation in Large Courses".

She is a Senior Fellow of Advance HE -- which indicates an advanced level of professional standing regarding her expertise in teaching and learning in higher education. In 2022, Sabine was appointed to the HEA@UQ Review Panel as an Assessor.

Sabine Matook produced in 2023 a train-the-trainer workshop for low-code development for the AIS Digital Academy.

Sabine also engages in the scientific scholarship of teaching with a focus on digital employability through citizen development. Her work is currently under review in high-quality academic journals, whereas Sabine published initial findings at the 2021 Australasian Conference on Information Systems and, in 2024, at the Journal of Information Technology and, in 2025, at Business & Information Systems Engineering.

An opinion piece at The Conversation about "How work-integrated learning helps to make billions in uni funding worth it" and an article in the Campus Section of the Times Higher Education about "Helping students to see the future career value of their work-integrated learning" reached a large readership and influenced the practices of science educators in Australia.

Service

Professor Matook is an active and engaged member of the scientific community in Australia and globally. She received multiple awards and recognitions for your extensive contributions to science.

Sabine Matook received the 2021 AIS Technology ATLAS Award. This award is given to scientists who have made the most significant contributions toward the intellectual infrastructure of the Association for Information Systems (AIS). In 2022, Sabine was awarded the AIS Vision Award to recognize her scientific contributions to the vision of the Association for Information Systems.

She is an Associate Editor for MIS Quarterly (MISQ), a Senior Editor for the European Journal of Information Systems (EJIS) and for the former journal AIS Transactions on Replication Research (TRR), a member of the editorial review board for Information System Research andJournal of Management Information Systems, and has been an Associate Editor for Information Systems Journal (ISJ).

Sabine Matook is the AIS Council Secretary for The Association for Information Systems (Sep 2021- 2027).

In 2019, Dr. Matook served on the Expert Panel 'Information Systems' that reviewed the 2019 Australian Business Deans Council Journal Quality List, and in 2022, she served on the Expert Panel that reviewed the 2020 journal ranking list of the Australian Council of Professors and Heads of Information Systems (ACPHIS)

Sabine Matook was the program chair for the European Conference on Information Systems (ECIS) in 2022 and 2021 and 2019. In addition, she served repeatedly as track chair for the International Conference on Information Systems (ICIS) [2025, 2023, 2029, 2015], the European Conference on Information Systems (ECIS) [2024-2026,2020], Pacific-Asian Conference on Information Systems (PACIS) in [2024, 2022, 2020], and the Australasian Conference on Information Systems [2018, 2019].